Nevertheless, researchers are exploring therapeutic strategies that could inhibit c-myc activity or downstream signaling pathways as a potential tool for treatment [94], especially to decrease the activity of ovarian cancer stem cells [95]. This evidence concerns the gene MYC and ovarian cancer.